Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder.

Progress in neuro-psychopharmacology & biological psychiatry - 1 Jan 2008

Masui Takuya, Hashimoto Ryota, Kusumi Ichiro, Suzuki Katsuji, Tanaka Teruaki, Nakagawa Shin, Suzuki Tatsuyo, Iwata Nakao, Ozaki Norio, Kato Tadafumi, Takeda Masatoshi, Kunugi Hiroshi, Koyama Tsukasa

Abstract excerpt

Lithium is one of the most commonly used drugs for the treatment of bipolar disorder. To prescribe lithium appropriately to patients, predictors of response to this drug were explored, and several genetic markers are considered to be good candidates. We previously reported a significant associati...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Antimanic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Asparagine

Share to Bipolar Disorder

Share to Gene Frequency

Share to Mutation, Missense

Share to Pharmacogenetics

Share to Serine

Source

Identifiers

PMID: 17822820
DOI: 10.1016/j.pnpbp.2007.08.010

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17822820-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder.PMID 17822820Read ↗

The breakpoint cluster region gene on chromosome 22q11 is associated with bipolar disorder.Semantic proximity Read ↗

Validating MARK2 Gene Polymorphism as a Predictor of Response to Lithium Treatment in Bipolar PatientsSemantic proximity Read ↗

Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.Semantic proximity Read ↗

Lithium response and genetic variation in the CREB family of genes.Semantic proximity Read ↗

Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients.Semantic proximity Read ↗

Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy.Semantic proximity Read ↗

Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder.Semantic proximity Read ↗

[Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients].Semantic proximity Read ↗

[Polymorphisms in the breakpoint cluster region of bcr gene].Semantic proximity Read ↗

Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder.Semantic proximity Read ↗

The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness.Semantic proximity Read ↗

Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.